Akshat Jain: Sickle Cell Disease Is Not One Size Fits All
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared a post on LinkedIn about a recent article he authored, published in Blood Global Hematology, adding:
“I’m pleased to share my new publication, ‘Sickle Cell Disease: from Genomic Epidemiology to Novel Therapeutics,’ now available in Blood Journals Portfolio GlobalHematology. Published during Sickle Cell Awareness Month.
This publication explores the continuum from genomic epidemiology to emerging therapeutics and underscores a central message: the future of sickle cell disease care must be precise, innovative, patient-centered, and equitable.
Asian sickle cell is different than African and that of Middle eastern geno and phenotype. It’s not one size fits all and that needs to be reflected in therapy.
Advances in genomic epidemiology are improving our understanding of disease burden, genetic modifiers, and variation in clinical outcomes across populations. At the same time, therapeutic innovation—from disease-modifying treatments to curative-intent cell and gene-based approaches—is reshaping what may be possible for individuals and families affected by SCD.
I am grateful to the patients, families, advocates, clinicians, researchers, and global partners whose voices and efforts continue to move the field forward.”
Title: Sickle Cell Disease: from Genomic Epidemiology to Novel Therapeutics
Authors: Akshat Jain
Find more posts featuring Akshat Jain on Hemostasis Today.
-
Sep 23, 2026, 00:08Janar Sathananthan: The Importance of Durable Drug Delivery in DCB Therapy
-
Sep 23, 2026, 00:07Arun V J: How Does a Good Conference Destroy My Ego?
-
Sep 23, 2026, 00:05Sherri Ozawa: Nicole De Vita’s Iron Deficiency Infographic Recognized at SABM
-
Sep 23, 2026, 00:04Zafar Ali: How Does Hemoglobin Know When to Hold Oxygen and When to Let It Go?
-
Sep 23, 2026, 00:02Ahmed Elsharkawy: Drug-Drug and Drug-Diluent Incompatibilities in ICUs and Hematology Units
-
Sep 22, 2026, 23:58Nishant Rajendra Tiwari: Hereditary TTP With the Same ADAMTS13 Variants but Strikingly Different Disease Courses
-
Sep 22, 2026, 23:57Akhil Santhosh: Pacritinib Versus Ruxolitinib in Myelofibrosis With Thrombocytopenia
-
Sep 22, 2026, 23:56Nathan Punwani: EASIX and sC5b-9 Predict TMA After Allogeneic Stem Cell Transplantation
-
Sep 22, 2026, 19:02Blocking Histone-Induced Platelet-Erythrocyte Interactions With Polyanions – Platelets Journal